Harrisvaccines is now part of Merck Animal Health. Please visit the Merck Animal Health LinkedIn page for more information! https://lnkd.in/b4pAgNB Harrisvaccines is revolutionizing the worlds' animal vaccine industry by providing herd-specific vaccines more quickly, safely and flexibly than any other brand. With its RNA Particle (RP) technology, the company is working to improve disease management and animal health. The RP technology Harrisvaccines deploys does not need the virus. Instead, it need only the data to determine the sub-type or strain of a specific virus. SirraVax takes the gene sequence from a diagnostic lab report to make every herd-specific vaccine rapidly, safely and economically. Porcine Epidemic Diarrhea vaccine, RNA - This product is Conditionally approved for safe, potent and reasonable expectation of efficacy against Porcine Epidemic Diarrhea virus (PEDv). Swine Influenza Vaccine, RNA - This products is licensed to be used as an aid in the prevention of disease caused by Swine Influenza, H3N2. United States Veterinary Biologics Establishment License Number 592.